EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Revolutionising Cardio-Oncology Care with Precision Genomics

Jun Hua Chong, Charles T H Chuah, Caroline G Lee iD

International Journal of Molecular Sciences · 26.02.2025 · 26 (5) · 2052

DOI: 10.3390/ijms26052052 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.02.2025. Verfasst von Jun Hua Chong und 2 weiteren Autor:innen. Beteiligte Einrichtung: National Heart Centre Singapore, 5 Hospital Dr, Singapore 169609, Singapore. Hauptthemen laut MEDLINE: Precision Medicine, Genomics, Cardiovascular Diseases, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 167 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health, Singapore Ministry of Health’s National Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular disease is the worldwide leading cause of mortality among survivors of cancer due in part to the cardiotoxicity of anticancer therapies. This paper explores the progress in precision cardio-oncology, particularly in genetic testing and therapeutics, and its impact on cardiovascular diseases in clinical and laboratory settings. These advancements enable clinicians to better assess risk, diagnose conditions, and deliver personalised, cost-effective therapeutics. Through case studies of cancer-therapy-related cardiac dysfunction, clonal haematopoiesis of indeterminate potential, and polygenic risk scoring, we demonstrate the benefits of incorporating precision genomics in individualised care in cardio-oncology. Furthermore, leveraging real-world genomic data in clinical settings can advance our understanding of long noncoding RNAs and microRNAs, which play important regulatory roles in cardio-oncology. Additionally, employing human-induced pluripotent stem cells to stratify risk and guide prevention strategies represents a promising avenue for modelling precision cardio-oncology. While these advancements showcase the significant progress in genetic approaches, they also raise substantial ethical, legal, and societal concerns. Regulatory oversight of genetic and genomic technologies should therefore evolve suitably to keep up with rapid advancements in technology and analysis. Provider education is crucial for the appropriate use of new genetic and genomic applications, including on the existing protection available for patients regarding genetic information. This can provide confidence for diverse study groups to advance genetic studies looking to develop a comprehensive understanding and effective clinical applications for heterogeneous populations. In clinical settings, the implementation of genetic and genomic applications within electronic medical records can offer point-of-care clinical decision support, thus providing timely information to guide clinical management decisions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precision MedicineGenomicsCardiovascular DiseasesNeoplasmsMedical OncologyHumansCardiotoxicityGenetic TestingCardio-Oncology

Stichwörter der Autor:innen

cancer-therapy-related cardiac dysfunctioncardio-oncologyclonal haematopoiesis of indeterminate potentialhuman-induced pluripotent stem cellslong noncoding RNAs and microRNAspolygenic risk scoringprecision genomics

Autor:innen und Institutionen

  • National Heart Centre Singapore, 5 Hospital Dr, Singapore 169609, Singapore.
  • Duke-NUS Medical School, 8 College Road, Singapore 169857, Singapore.
  • National Cancer Centre Singapore, 30 Hospital Blvd, Singapore 168583, Singapore.
  • Singapore General Hospital, Outram Road, Singapore 169608, Singapore.
  • Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, C/O MD7, Level 2, 8 Medical Drive, Singapore 117597, Singapore.
  • Division of Cellular & Molecular Research, Humphrey Oei Institute of Cancer Research, National Cancer Centre Singapore, 11 Hospital Crescent, Singapore 169610, Singapore.

ORCID-Profile: Caroline G Lee

Förderung

  • Ministry of Health, Singapore Ministry of Health’s National Medical Research Council

Zitieren

APA

Chong, J. H., Chuah, C. T. H., & Lee, C. G. (2025). Revolutionising Cardio-Oncology Care with Precision Genomics. International Journal of Molecular Sciences, 26(5), 2052. https://doi.org/10.3390/ijms26052052

Vancouver

Chong JH, Chuah CTH, Lee CG. Revolutionising Cardio-Oncology Care with Precision Genomics. International Journal of Molecular Sciences. 2025;26(5):2052. doi:10.3390/ijms26052052

BibTeX
@article{Chong2025,
  author = {Chong, Jun Hua and Chuah, Charles T H and Lee, Caroline G},
  title = {Revolutionising Cardio-Oncology Care with Precision Genomics},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {5},
  pages = {2052},
  doi = {10.3390/ijms26052052}
}
Kostenlos starten →